Umoja Biopharma
Published indications, not live orders. Newest first; matching records grouped.
Latest observed . Availability is not verified.
Buyers 0
No published buyers.
Sellers 5
| Date | Price / size | Broker | Terms |
|---|---|---|---|
| UnpricedSize undisclosed | Setter Capital | Not specifiedNotesListed under past four days' inventory with supply available. | |
| UnpricedSize undisclosed | Setter Capital | Not specifiedNotesListed as supply in the past four days' inventory; terms not provided. | |
| UnpricedSize undisclosed | Setter Capital | Not specifiedNotesSupply listed in past four days' inventory; terms not provided. | |
| UnpricedSize undisclosed | Setter Capital | Not specifiedNotesSupply listed in past four days inventory. | |
| UnpricedSize undisclosed | Setter Capital | Not specifiedNotesListed in the latest daily inventory with supply available; block details were not provided. |
Financing history
| Round | Date | Raised | Pre-money | Post-money | Price / share | Investors |
|---|---|---|---|---|---|---|
| Series C | Jan 19, 2025 | $100M | $320M | $420M | $3.95 | Alexandria Venture Investments, ARK Investment Management +15
|
| Series B | Jun 15, 2021 | $210M | $450M | $660M | $9.85 | AbbVie Ventures, Alexandria Venture Investments +13
|
| Series A | Nov 18, 2020 | — | — | — | — | — |
| Seed Round | Nov 21, 2019 | — | — | — | — | — |
PitchBook cached data. Investor participation is historical, not proof of current ownership. Lead labels appear only when reported. Missing details remain unspecified.
Investor participation · 23 names in the returned rounds
| Investor | Reported rounds |
|---|---|
| AbbVie Ventures | Series B · 2021-06-15 |
| Alexandria Venture Investments | Series C · 2025-01-19 Series B · 2021-06-15 |
| ARK Investment Management | Series C · 2025-01-19 |
| ARK Ventures (US) | Series C · 2025-01-19 |
| CaaS Capital Management | Series C · 2025-01-19 Series B · 2021-06-15 |
| Casdin Capital | Series B · 2021-06-15 |
| Cormorant Asset Management | Series C · 2025-01-19 Series B · 2021-06-15 |
| DCVC Bio | Series C · 2025-01-19 Series B · 2021-06-15 |
| Double Point Ventures | Series C · 2025-01-19 |
| Emerson Collective | Series C · 2025-01-19 Series B · 2021-06-15 |
| K2 HealthVentures | Series C · 2025-01-19 |
| Leerink Partners | Series B · 2021-06-15 |
| MPM BioImpact | Series C · 2025-01-19 Series B · 2021-06-15 |
| Myeloma Investment Fund | Series C · 2025-01-19 |
| Presight Capital | Series B · 2021-06-15 |
| Qiming Venture Partners USA | Series C · 2025-01-19 Series B · 2021-06-15 |
| Realm Capital Ventures | Series C · 2025-01-19 |
| RTW Investments | Series C · 2025-01-19 Series B · 2021-06-15 |
| SoftBank Investment Advisers | Series C · 2025-01-19 Series B · 2021-06-15 |
| Temasek Holdings | Series B · 2021-06-15 |
| Third Point Ventures | Series C · 2025-01-19 |
| University of Minnesota | Series C · 2025-01-19 |
| WRF Capital | Series B · 2021-06-15 |
Cached deal details · 4 rounds
| Round / date | Type / status | Investors | Exiting investors | Stored on |
|---|---|---|---|---|
| Series C2025-01-19 | Later Stage VCCompleted | Alexandria Venture Investments, ARK Investment Management +15
| Not specified | 2026-10-15 |
| Series B2021-06-15 | Early Stage VCCompleted | AbbVie Ventures, Alexandria Venture Investments +13
| Not specified | 2026-10-15 |
| Series A2020-11-18 | Not specifiedStatus not specified | — | Not specified | 2026-10-15 |
| Seed Round2019-11-21 | Not specifiedStatus not specified | — | Not specified | 2026-10-15 |
Stored on is the local round-record date, not the last time PitchBook verified it. No new provider lookups run when this page is opened.
Share classes
| Series | Issue price | Liq. preference | Ownership | Shares authorized |
|---|---|---|---|---|
| Series C | $3.95 | 1× | 23.81% | 25,285,601 |
| Series B-1 | $7.88 | 1× | 0.01% | 11,337 |
| Series B | $9.85 | 1× | 23.8% | 23,968,974 |
| Series A-2 | $2.72 | 1× | 9.75% | 10,353,412 |
| Series A-1 | $1.44 | 1× | 0.12% | 122,710 |
| Series A | $1.80 | 1× | 14.25% | 15,034,465 |
| Seed 1 | $2.24 | 1× | 0.6% | 565,996 |
| Seed | $2.80 | 1× | 2.81% | 2,400,773 |
Suggest a correction · Active members can send a private report for admin review.